Alon Ben-Noon
Mr. Ben-Noon is the Co-Founder and CEO of NeuroSense Therapeutics. Prior to the establishment of NeuroSense, Alon founded MediCan Consulting, a successful consultancy firm, with clients from diversified biotech companies, including Mediwound, Chiasma, Teva, Sol-Gel, FutuRx, NeuroDerm and others. MediCan excelled at executing efficient, accurate, and innovative drug development programs for its clients. Mr. Ben-Noon […]
Dr. Ferenc Tracik
Dr. Ferenc Tracik, our chief medical officer has twenty years of experience in general management, medical affairs, clinical development and commercialization in the biotech industry. Before joining the Company, he served as the Global Head Medical of Orphazyme A/S. From May 2017 until November 2020, Dr. Tracik served as VP Medical Europe, Canada and Partner […]
Dr. Niva Russek-Blum
Dr. Niva Russek- Blum has over 17 years of experience in neuroscience, specifically Parkinson’s disease and ALS. Niva established her lab in 2012, leading research as a Principle Investigator under the auspices of Ben Gurion University, focusing on neurological and immune perspectives of neurodegenerative diseases. She established a CRO, utilizing high throughput-screening infrastructure required for […]
Hagit Binder
Ms. Hagit Binder has over 13 years of experience in the drug development industry. Previously, Ms. Binder held VP projects and a marketing position at Nextar Chempharma solutions. She has led projects in various therapeutic areas for both local and global companies. In addition, she oversaw all projects, was accountable for deliverables and adherence to […]
Or Eisenberg
CFO at NeuroSense Therapeutics. Mr. Eisenberg is a registered CPA with broad experience in all aspects of public companies in Israel and in the US.Prior to joining NeuroSense, he served in several financial management positions in the biotech industry, including CFO and acting CEO of Wize Pharma Inc.Prior to that, Or served as controller of […]
Dr. Sharon Cohen Vered
Dr. Cohen Vered leads the CMC development at NeuroSense Therapeutics. She has been a development and operations executive for over 25 years, and has experience leading drug development (CMC) teams in the pharmaceutical industry, both in large multinational corporations as well as in startup environments. Prior roles include VP CMC at NeuroDerm for 10 years, […]
Diana Shtossel
Ms. Diana Shtossel has over 15 years of vast knowledge and expertise in Regulatory Affairs and in all aspects of drug development throughout the product life cycle. Ms. Shtossel has a significant experience in development and registration of Drugs, Biologic Products, Combination Products and Medical Devices in US, EU, Canada, Israel and Rest of the […]
Dr. Shiran Zimri
Dr. Zimri is the VP of R&D at NeuroSense Therapeutics, leading the research and development programs for ALS, Parkinson’s disease, and Alzheimer’s disease.Shiran is a pre-clinical drug development expert, with over 12 years of experience studying neurodegenerative diseases utilizing multidisciplinary methods. She has been published in leading journals and has presented at scientific conferences worldwide. […]
Yael Barak
Yael has over 18 years of experience in quality management system (QMS) and pharmacovigilance (PV) throughout the product life cycle. In her previous positions, she held different roles in Teva’s PV organization, among them: GVP auditor, PV training manager, Operations manager and in the last 8 years she led the global PV compliance group of […]
Nedira Salzman-Frenkel
Mrs. Salzman-Frenkel is the VP of Business Development at NeuroSense Therapeutics, spearheading all industry partnerships and investor relations. Nedira has been in the biotech industry for over 10 years. In her last role as CEO of Salzman Group, her company raised $84M in US federal government funding. She has founded 5 companies in the last […]
Dorit Jacob
Dorit has over 14 years of experience in the Regulatory Affairs field, from early stages of product development to regulatory registration, submissions and approval of Drugs and Cell Therapy Products in different markets such as the USA, EU and Israel. Previously, she held the position of Regulatory Affairs Manager at Gamida Cell Ltd., and Regulatory […]
Vered Sasson
Vered is a certified CRA, with over six years of experience in the clinical trial field and health sciences. In her previous positions, she was head of a study coordinators team at a leading diabetes medical center, conducting multiple nephrology, cardiology and diabetes studies (phases 2 & 3). Vered also held an In house CRA […]
Eidan Loushi
Eidan is a certified CRA with an M.Sc. in biomedicine from Tel-Aviv university faculty of Medicine. In his previous position, Eidan was a CRA and project leader in the hematology institution of Tel-Aviv medical center (Ichilov), leading investigator-initiated multi-center studies in the field of Haemato-oncology. Eidan holds B.Sc. in biology with a focus on immunology […]
Nitai Kerem
Nitai brings extensive scientific experience gained during his time in academia. Having worked as a lead researcher and as a research assistant in several large-scale studies involving collaborations with esteemed PIs and universities, Nitai has developed invaluable expertise in navigating the complexities of scientific research. With experience in neuroimaging and a variety of behavioural methods, […]
Keren Pushett
Keren is the initiator and leader of our HR activities.She also manages shareholder and patient communications, as well as additional administrative duties. In her previous positions, she has managed multiple teams of diverse backgrounds, and also has experience in customer services and website management.
